Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Coronary Artery Disease Clinical Trials

118 recruiting trials for Coronary Artery Disease. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
118
Total Trials
118
Recruiting Now
6
Phase 3 Trials
10
Sponsors

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT04844944

The Helios Heart Registry: A Standardized Registry for Patients With Specific Cardiac Diseases

Investigator-initiated, prospective, non-randomized, open label, non-interventional multicenter registry to evaluate current treatment of three major cardiovascular disease...

Sponsor: Helios Health Institute GmbHEnrolling: 2400010 locations
RECRUITINGNCT04976348

The Multicenter Cardiology Monitoring Platform Registry

The multicenter Cardiology Monitoring Platform registry (mCMP-registry) is a prospective observational registry including multi-omics (diagnostic) measurements performed as part...

Sponsor: Maastricht University Medical CenterEnrolling: 400001 location
RECRUITINGPhase 2NCT06620523

Prevent Cardiac Surgery Associated AKI Trial

Prevent CSA-AKI (Cardiac Surgery Associated Acute Kidney Injury) trial is a double blinded randomized controlled trial, 242 patients undergoing elective cardiopulmonary bypass...

Sponsor: George Washington UniversityEnrolling: 2421 location
RECRUITINGNCT04126148

Breathing-Maneuver-Induced Myocardial Oxygenation Reserve Validated by FFR (B-MORE)

The study aims to determine a diagnostic marker for regionally impaired myocardial oxygenation response in patients with suspected coronary artery stenosis.

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health CentreEnrolling: 3501 location
RECRUITINGPhase 3NCT07297589

Epicardial Cardiac Fat-CT (EPIC-CT)

Both globally and nationally, heart disease remains the leading cause of death overall and across genders, with ischemic heart disease being the primary cause. It is now...

Sponsor: Instituto Mexicano del Seguro SocialEnrolling: 1361 location
RECRUITINGPhase 2NCT05926271

POPular GUILTY PILOT: Genotype-guided Clopidogrel Monotherapy

The goal of this pilot clinical trial is to test the safety and effectiveness of genotype-guided clopidogrel monotherapy in patients presenting with Non-ST-Segment Elevation Acute...

Sponsor: St. Antonius HospitalEnrolling: 2001 location
RECRUITINGNCT06567249

Intracoronary Hypothermia as a Prevention of Reperfusion Injury in Myocardial Infarction.

Acute myocardial infarction with ST segment elevation is often accompanied by a totally occluded coronary artery. Which has deleterious effects on heart muscle. Primary...

Sponsor: Tomsk National Research Medical Center of the Russian Academy of SciencesEnrolling: 601 location
RECRUITINGNCT05078814

The Prevalence Survey of ALDH Gene Family in Patients With Peripheral Arterial Occlusive Disease or Acute Coronary...

Aldehyde dehydrogenase 2 (ALDH2) is an important enzyme protecting human from the accumulation of aldehyde, the main metabolites of alcohol. The deficiency of ALDH2 gene results...

Sponsor: Chimei Medical CenterEnrolling: 6001 location
RECRUITINGNCT04464655

A 10-Minute Cardiovascular Magnetic Resonance Protocol for Cardiac Disease

This study aims to identify and assess new CMR techniques that can improve current CMR protocols.

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health CentreEnrolling: 21301 location
RECRUITINGNCT06603363

Changes in Plaque Characteristics After Short-term Statin Therapy as Assessed With Coronary CT

INTENSE Trial is a prospective, double-blind, randomized, placebo-controlled, single-center study with two arms (40 mg intensified statin therapy vs matching placebo for...

Sponsor: Prof. Maurovich-Horvat PálEnrolling: 1401 location
RECRUITINGNCT05770687

SGLT2 Inhibitors on Clinical Outcomes and Left Ventricular Remodeling in Type 2 Diabetic Patients with Acute Myocardial...

Prospective trials performed on type 2 diabetes patients without established cardiovascular disease has shown that SGLT2 inhibitors reduce cardiovascular risk. No studies have yet...

Sponsor: Kiyuk ChangEnrolling: 10001 location
RECRUITINGNCT07316452

Risk Prediction of Disease Progression in Early-Onset Coronary Atherosclerosis

This study is part of a nationwide research project in China that aims to better understand how coronary artery disease develops and progresses in young adults. The study will...

Sponsor: Fu Wai Hospital, Beijing, ChinaEnrolling: 100001 location
RECRUITINGNCT03209414

Frailty Syndrome in Daily Practice of Interventional Cardiology Ward

The impact of frailty on immediate and long term outcomes of invasive treatment of coronary artery disease is not fully characterized. The assessment of frailty may help...

Sponsor: Medical University of SilesiaEnrolling: 10001 location
RECRUITINGNCT05967663

Fractional Flow Reserve Guided Immediate Versus Staged Complete Myocardial Revascularization in Patients With...

It is a prospective, multicenter, randomised controlled, open-label, blinded endpoint assessment trial, to compare the strategy of immediate complete revascularisation and staged...

Sponsor: RenJi HospitalEnrolling: 8401 location
RECRUITINGNCT04674449

iCorMicA - Stratified Medicine in Angina

The iCorMicA study is a multicentre, prospective, randomised, double-blind, sham-controlled, parallel-group, end-point trial and registry. The investigators seek to determine...

Sponsor: NHS Greater Glasgow and ClydeEnrolling: 15002 locations
RECRUITINGNCT06669884

Use of Determine Learning-based Cardiodynamicsgram (CDG) for Rapid and Precise Stratification of Chest Pain in...

Chest pain accounts for 10-20 percent of all emergency department visits. The stratification of chest pain is always a challenge. Electrocardiograms (ECG) have been used in...

Sponsor: Qilu Hospital of Shandong UniversityEnrolling: 80001 location
RECRUITINGNCT06951867

Tezspire Cardiac Events PASS

The aim of this study is to evaluate the risk of serious adverse cardiovascular events in adolescent and adult patients with severe asthma taking tezepelumab compared to a...

Sponsor: AstraZenecaEnrolling: 166404 locations
RECRUITINGNCT06203860

The Cardio-Metabolic Clinic

This study aims to investigate whether a Cardio-Metabolic Clinic can protect the cardiovascular health of patients with both diabetes and cardiovascular disease. * At the...

Sponsor: Odense University HospitalEnrolling: 16001 location
RECRUITINGNCT05681858

Plaque Burden and Ischemia in MINOCA

The goal of this clinical trial is to assess coronary artery plaque burden, perivascular inflammation and extent of myocardial ischemia in patients presenting with acute...

Sponsor: University of BergenEnrolling: 1001 location
RECRUITINGNCT04973397

Vascular Events In Patients Undergoing Same-day Noncardiac Surgery (VALIANCE) Study

The proportion of noncardiac surgeries performed as same-day surgery is increasing worldwide, with more complex surgeries being performed on higher risk patients in the outpatient...

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)Enrolling: 1500016 locations
RECRUITINGNCT05075317

Time Restricted Eating and Cardiac Rehabilitation

This study will use a form of intermittent fasting called time-restricted eating (TRE) where individuals consume ad libitum energy intake within a set window of time, commonly 8...

Sponsor: University of TorontoEnrolling: 601 location
RECRUITINGNCT07259278

Intelligent Management Platform for Guiding Exercise Rehabilitation in Coronary Heart Disease Patients

The goal of this clinical trial is to find out if an artificial intelligence (AI)-enabled stratified management platform can help adults with coronary heart disease (CHD) better...

Sponsor: China National Center for Cardiovascular DiseasesEnrolling: 2001 location
RECRUITINGPhase 4NCT05527717

Revascularization Strategy of Multivessel Disease for Patients with Acute Myocardial Infarction Complicated by...

This study is a prospective, open-label, two-arm, randomized multicenter trial to identify whether immediate multi-vessel PCI would be better in clinical outcomes compared with...

Sponsor: Samsung Medical CenterEnrolling: 5601 location
RECRUITINGPhase 1NCT02966665

: Vascular Function in Health and Disease

Many control mechanisms exist which successfully match the supply of blood with the metabolic demand of various tissues under wide-ranging conditions. One primary regulator of...

Sponsor: Russell RichardsonEnrolling: 4201 location
RECRUITINGNCT07094737

The Italian Alliance for Cardiovascular Rehabilitation and Prevention (ITACARE-P) Registry: An Observational Study on...

ITACARE-P CardioRehab Registry is a nationwide observational study conducted in Italy and coordinated by the Fondazione Don Carlo Gnocchi in Milan. It involves multiple hospitals...

Sponsor: Fondazione Don Carlo Gnocchi OnlusEnrolling: 16001 location
RECRUITINGNCT04682483

Cardiogenic Shock Working Group Registry

The Cardiogenic Shock Working Group is a multicenter registry where we collect de-identified clinical variables from the medical records and follow-up phone calls of shock...

Sponsor: Tufts Medical CenterEnrolling: 500016 locations
RECRUITINGNCT05762601

Cellular precOnditioning for Post-Surgical Myocardial Ischemic Complications - Observational Study

The goal of this observational study is to collect health data on people who are at high risk of having heart complications and are having a surgery that is not on the heart. The...

Sponsor: Ottawa Hospital Research InstituteEnrolling: 121 location
RECRUITINGPhase 4NCT05643651

Rivaroxaban for Children Aged Over 2 Years With Giant Coronary Artery Aneurysms After Kawasaki Disease

Based on population pharmacokinetic model-based simulation, a 15 mg-equivalent, age-, and bodyweight-adjusted dosing regimen for Chinese children with giant coronary artery...

Sponsor: Children's Hospital of Fudan UniversityEnrolling: 1001 location
RECRUITINGNCT06014112

Predictive Value of Glycemic Parameters Measured With the FSL Pro iQ During ACS

Disorders of glycemic regulation are common in patients hospitalized for acute coronary syndrome (ACS). Abnormal glycaemia is observed in 50% of cases, in 30-40% diabetes, and in...

Sponsor: University Hospital, MontpellierEnrolling: 8509 locations
RECRUITINGPhase 4NCT06186037

Clinical Comparison of Low-dose Rosuvastatin Plus Ezetimibe Combination Therapy and High-dose Rosuvastatin Monotherapy...

\[Purpose of the Clinical Study\]:The purpose of this study is to conduct a clinical comparison of low-dose rosuvastatin plus ezetimibe combination therapy and high-dose...

Sponsor: Saint Vincent's Hospital, KoreaEnrolling: 63561 location
RECRUITINGNCT06126367

Assessment of Lipoprotein(a) and Endogenous Fibrinolysis in Atherosclerotic Cardiovascular Disease/Aortic Valve Disease

Prior studies have shown that impaired endogenous fibrinolysis is a novel, independent cardiovascular risk factor in patients with myocardial infarction and there is currently no...

Sponsor: East and North Hertfordshire NHS TrustEnrolling: 1801 location
RECRUITINGNCT06448637

DRUG RELEASING BALL vs. PHARMACOACTIVE STENT IN LARGE VESSELS: MORPHOLOGICAL ANALYSIS AND FUNCTION VASOMOTOR (DEBORA...

Randomized, controlled, open and multicenter study that analyzes the vasomotor function 8 months after use of the drug-eluting balloon (DCB) vs. drug-eluting stent (DES) in...

Sponsor: Fundación EPICEnrolling: 947 locations
RECRUITINGNCT07107971

Drug-Eluting Balloon Treatment vs. Guideline-Directed Medical Therapy for the Treatment of Lipid-Rich Plaques

The goal of this clinical trial is to find out whether treating vulnerable plaques in the coronary arteries with a drug-coated balloon can make them less dangerous than using...

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Enrolling: 4001 location
RECRUITINGPhase 2NCT06572267

Safety and Efficacy of Meplazumab in Patients With Coronary Artery Disease

The development of coronary atherosclerosis is closely related to inflammation, and CD147 may play an important role in its process. The present study was designed to evaluate the...

Sponsor: Xijing HospitalEnrolling: 181 location
RECRUITINGPhase 4NCT03378934

Anti-platelet Effect of Berberine in Patients After Percutaneous Coronary Intervention

The APLABE-PCI is a single-center, randomized, open-label, controlled, dose-escalating, parallel-group study, which is designed to assess the anti-platelet effect of berberine in...

Sponsor: Peking Union Medical College HospitalEnrolling: 641 location
RECRUITINGPhase 4NCT04937699

Sequential MonotherApy of TicagrElor and Clopidogrel After Coronary Intervention

The MATE study is a randomized, multicenter, open-label, investigator-initiated clinical trial aimed to evaluate efficacy and safety of sequential monotherapy of ticagrelor and...

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang UniversityEnrolling: 26901 location
RECRUITINGPhase 4NCT06723145

Optimal PERioperative Antiplatelet Therapy Investigation ON Abdominal Surgery After Coronary Stent Implantation

The purpose of this study is to evaluate the impact of perioperative aspirin continuation on clinical outcomes in patients with a history of coronary stent implantation who are...

Sponsor: Kyoto UniversityEnrolling: 12001 location
RECRUITINGNCT07291609

Microplastics and Nanoplastics in Patients With Chronic Coronary Syndromes

The CCS-plastics is an investigator-initiated, prospective, multicenter study of patients undergoing coronary CT angiography (CCTA) for suspected or known chronic coronary...

Sponsor: Azienda Ospedaliera "Sant'Andrea"Enrolling: 1206 locations
RECRUITINGPhase 4NCT05708859

Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT

A multi-center, randomized, double-blind, placebo-controlled, parallel-group phase IV Study evaluating the effects of tirzepatide on atherosclerotic plaque progression assessed by...

Sponsor: Matthew J. BudoffEnrolling: 1201 location
RECRUITINGNCT05698732

Coroflex® ISAR NEO PMCF Study

International, Multicenter, prospective, non-randomized, post-market clinical follow-up (PMCF) study to confirm and support the clinical safety and performance of Coroflex® ISAR...

Sponsor: Fundación EPICEnrolling: 300020 locations
RECRUITINGPhase 3NCT04020263

Effect of Early Use of Levosimendan Versus Placebo on Top of a Conventional Strategy of Inotrope Use on a Combined...

Cardiogenic shock (CS) mortality remains high (40%). Despite their frequent use, few clinical outcome data are available to guide the initial selection of vasoactive drug...

Sponsor: Pr Bruno LEVYEnrolling: 61020 locations
RECRUITINGNCT00794001

Feedback Intervention and Treatment Times in ST- Elevation Myocardial Infarction

Part I (Pilot Phase): The purpose of this study is to examine if formalized data assessment and systematic feedback improves treatment times (i.e. contact-to-balloon time and...

Sponsor: Karl Heinrich ScholzEnrolling: 500001 location
RECRUITINGNCT05788432

Sequent Extended Study

Multicenter, prospective, non-randomized, post-market clinical follow-up (PMCF) study to confirm and support the clinical safety and performance of Sequent Please Neo to meet EU...

Sponsor: Fundación EPICEnrolling: 202820 locations
RECRUITINGNCT05412927

AngelMed Guardian® System PMA Post Approval Study

500 Patients (minimum) will be enrolled following commercial implant. Will be treated by their physicians using the standard of care. Standard of care for the Guardian includes...

Sponsor: Angel Medical SystemsEnrolling: 50018 locations
RECRUITINGPhase 4NCT07349875

Colchicine Treatment for Non-Flow-Limiting Coronary Plaque by Coronary CTA: A Randomized Controlled Trial

This study is a prospective, multicenter, randomized controlled clinical trial designed to evaluate whether an anti-inflammatory medication can help improve heart health in...

Sponsor: Nanjing First Hospital, Nanjing Medical UniversityEnrolling: 38261 location
RECRUITINGNCT06353594

Reduced Stent Strategy Versus Conventional Percutaneous Coronary Revascularization in Patients Presenting With STEMI

The objective is to compare a reduced stent strategy based on drug-coated balloon (DCB) percutaneous coronary intervention (PCI) with conventional drug-eluting stent (DES)...

Sponsor: Jorge Sanz SanchezEnrolling: 127215 locations
RECRUITINGNCT04193475

Machine Learning in Quantitative Stress Echocardiography

Greater diagnostic accuracy is required to find out who is at risk of a heart attack as this can reduce the requirement of more invasive downstream tests and thereby improve the...

Sponsor: Hull University Teaching Hospitals NHS TrustEnrolling: 12501 location
RECRUITINGNCT04612322

MICRO: a Registry Study in Patients With Microvascular Angina

The evidence above demonstrates that microvascular dysfunction is an important determinant of patient prognosis, which however remains poorly classified. Given the high burden of...

Sponsor: Johannes Gutenberg University MainzEnrolling: 10001 location
RECRUITINGNCT04950218

Prevalence and Risk Factors asSOciated With CArdiac comorbiDIty in psoriAsis

In a prospective cohort study (n = 1.000), the investigators aim to investigate the correlation between cardiac biomarkers and advanced echocardiography and determine whether...

Sponsor: Herlev and Gentofte HospitalEnrolling: 10001 location
RECRUITINGNCT05524324

Cardiac Resynchronization Therapy in Adult Congenital Heart Disease With Systemic Right Ventricle: RIGHT-CRT

The main objective of RIGHT-CRT is to assess the impact/efficacy of CRT on functional capacity in ACHD patients with SRV.

Sponsor: Assistance Publique - Hôpitaux de ParisEnrolling: 4013 locations

Showing 50 of 118 trials.Search all Coronary Artery Disease trials

Frequently Asked Questions

There are currently 118 clinical trials for Coronary Artery Disease, with 118 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Coronary Artery Disease, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 6 Phase 3 trials for Coronary Artery Disease, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice — always talk to your doctor about clinical trial participation.